Head And Neck Cancers

Infant's Tongue Lesion Mimics Neoplastic Growth

April 10, 2017

"This case reinforces the role of tissue culture when histology fails to demonstrate a diagnosis and emphasizes the need for efficient communication between the pediatrician, otolaryngologist, and pathologist for timely excision," the authors write.

Could Cannabidiol Be Effective for Oral Mucositis?

February 16, 2017

Cannabidiol could be beneficial for the treatment of oral mucositis, although data on its use in dentistry are scarce, according to a review published online February 12 in the Journal of Clinical Pharmacy and Therapeutics.

Serious Comorbities Remain a Risk for HIV Patients on ART

October 28, 2016

For patients taking antiretroviral medications, HIV continues to reside in tissues, and though this may not cause AIDS, it could contribute to the development of unrelated conditions such as cancer and cardiovascular disease, according to research published in the October issue of the Journal of Virology.

FDA Grants Accelerated Approval for Keytruda in HNSCC

By August 08, 2016

Merck announced that the Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) with disease progression on or after platinum-containing chemotherapy.

Amneal Initiates Temporary Import of Cancer Drug Due to Shortage

By July 13, 2016

Amneal Biosciences announced that due to the current shortage of Bleomycin Sulfate for Injection, USP, 15 Units and 30 Units per vial, they have initiated a temporary importation of Bleomycin Sulfate Powder for Injection 15,000 IU per vial to the market.

Most HPV-Related Cancers Are Preventable, Says CDC Report

July 08, 2016

The majority of cancers linked to human papillomavirus (HPV) are preventable, according to a report published in the July 8 issue of the US Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Glioblastoma Immune Genes Identified in New Study

May 26, 2016

Researchers have identified immune genes that may affect mortality in patients with glioblastoma multiforme, according to a study published online in Neurology.

Greater Identification is Leveling off Thyroid Cancer Rates in U.S.

April 15, 2016

Fewer thyroid cancers are diagnosed in the United States now than in the recent past, perhaps signaling a change in physician practices.

Adding Chemo to Radiation Therapy Extends Lives by Years in Glioma Patients

April 07, 2016

Adding chemotherapy to radiation treatment may add years to the lives of patients with grade 2 gliomas, according to research published in the April 7 issue of the New England Journal of Medicine.

Benefits of Image-Guided Surveillance Highlighted for Head, Neck Cancer

March 24, 2016

Image-guided surveillance seems beneficial for patients with squamous-cell carcinoma of the head and neck who have advanced nodal disease, according to a study published online in the New England Journal of Medicine.

Cancer Deaths Declining by 1.5% a Year in the U.S.

March 10, 2016

Overall rates of cancer and cancer mortality in the United States continue to decline, according to the Annual Report to the Nation on the Status of Cancer.

Increase in Weight, Height Among Teens Linked to Non-Hodgkin's Lymphoma

February 23, 2016

Higher body weight and taller stature during adolescence are associated with increased risk of non-Hodgkin's lymphoma (NHL), according to a study published online in 'Cancer'.

Neuroprotective Qualities of Vit E Tested Against Cisplatin Ototoxicity

February 16, 2016

Vitamin E supplementation can reduce cisplatin (CDDP)-induced ototoxicity, according to a study published online in Head & Neck.

Teva Launches Generic Taxotere Injection

By February 12, 2016

Teva announced the launch of Docetaxel Injection, the generic version of Taxotere Injection Concentrate.

Study on Opdivo for Head, Neck CA Halted Early

By January 28, 2016

Bristol-Myers Squibb announced that the CheckMate -141 trial evaluating Opdivo (nivolumab) vs. investigator's choice in patients with recurrent or metastatic platinum-refractory squamous cell carcinoma of the head and neck (SCCHN) was stopped early due to the study meeting its primary endpoint.

Demographic Differences in Pediatric vs. Adult Nasopharyngeal CA Patients

January 22, 2016

Pediatric patients with nasopharyngeal carcinoma (NPC) are more often black and present with stage IV disease, but they have lower mortality than adult patients, according to a study published online in JAMA Otolaryngology-Head & Neck Surgery.

Fluorescence Visualization-Guided Sx Linked to Recurrence of Oral CA

January 20, 2016

For patients with oral cancer, fluorescence visualization (FV)-guided surgery is associated with a reduction in local recurrence, according to a study published online January 14 in JAMA Otolaryngology-Head & Neck Surgery.

Geography May be an Independent Risk in HPV Oropharyngeal Cancer Prevalence

January 15, 2016

There is geographic variation in the proportion of head and neck cancers attributable to human papillomavirus (HPV)

Head and Neck Cancer Patients Tx may be Affected by Provider Volume, Study Claims

January 07, 2016

For patients with head and neck cancer (HNC) treated with intensity-modulated radiation therapy (IMRT), provider volume is associated with outcome, according to a study published online January 4 in the Journal of Clinical Oncology.

FDA Approves Non-Alcohol Formula of Docetaxel Injection

By December 28, 2015

Eagle Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Docetaxel Injection, Non-Alcohol Formula, for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

First Emergency Tx Approved for 5-FU, Capecitabine Overdose

By December 11, 2015

The FDA has approved Wellstat Therapeutics' Vistogard (uridine triacetate) oral granules, the first treatment for patients following an overdose of 5-fluorouracil (5-FU) or capecitabine,

Loss of Heterozygosity Validated As Marker for Oral Cancer

November 06, 2015

EGFR inhibitor erlotinib doesn't improve cancer-free survival in high-risk LOH-positive patients

Neuromuscular Stimulation Doesn't Aid Dysphagia Patients

October 23, 2015

Combining NMES with swallow exercises in head and neck cancer patients not helpful

Statistical Tool May Predict Risk of Major Postop Complications

October 16, 2015

A statistical tool can accurately estimate an individual patient's risk of developing a major complication after surgery for oral cavity squamous cell carcinoma.

High-Dose Hypofractionated RT Palliative in Head, Neck Cancer

October 06, 2015

For patients with incurable head and neck cancer, high-dose hypofractionated radiotherapy (RT) is associated with meaningful palliative effect.

Significant Disparities in Care for Pediatric Retinoblastoma

October 06, 2015

Significant disparities in care and outcomes exist for children with retinoblastoma, according to a study published in JAMA Pediatrics.

No Specific Findings to ID Recurrence in Head and Neck CA

September 25, 2015

For patients treated for head and neck squamous cell carcinoma (HNSCC), no definite index of symptoms or signs indicates local recurrence or second primary malignancy.

Hematologic Markers Predict Nasopharyngeal Cancer Survival

September 22, 2015

High neutrophil-lymphocyte, platelet-lymphocyte ratios tied to shorter survival

Metformin Linked to Lower Risk of Head, Neck Cancer

September 09, 2015

Metformin is associated with a lower risk of developing head and neck cancer in patients with diabetes, according to a study published in Head & Neck.

Scope of Lymphadenectomy Not Tied to Esophageal CA Survival

September 04, 2015

For patients undergoing esophageal cancer surgery, the extent of lymphadenectomy seems not to influence all-cause or disease-specific survival.